Clinical Trials Browser

Muscle Invasive Bladder Urothelial Carcinoma

Urinary Bladder Neoplasms

Urinary Bladder Neoplasms

Urinary Bladder Neoplasms

Ureteral Neoplasms

Urinary Bladder Neoplasms

Urinary Bladder Neoplasms

Urinary Bladder Neoplasms

Non-Muscle Invasive Bladder Neoplasms, Neoplasms

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

Urinary Bladder Neoplasms, Carcinoma in Situ

Urinary Bladder Neoplasms

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

Prostatic Neoplasms

Anxiety Disorders, Urinary Bladder Neoplasms, Hematuria, Pain

Urinary Bladder Calculi, Urinary Bladder Neck Obstruction, Urinary Bladder Neoplasms, Kidney Diseases, Nephrolithiasis

Urinary Bladder Diseases, Urinary Bladder Neoplasms, Carcinoma in Situ

Urinary Bladder Neoplasms, Hematuria

Urinary Bladder Neoplasms

Urinary Bladder Neoplasms, Hematuria, Pain, Prostatic Hyperplasia, Lower Urinary Tract Symptoms

Urinary Bladder Neoplasms

Urinary Bladder Neoplasms

Urinary Bladder Neoplasms

Clinical Trials

Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

A Study of Chemotherapy and Radiation Therapy Compared to Chemotherapy and Radiation Therapy Plus MEDI4736 (Durvalumab) Immunotherapy for Bladder Cancer Which Has Spread to the Lymph Nodes, INSPIRE Trial

Consolidative Therapy After EV + Pembrolizumab in Muscle Invasive Bladder Cancer, REINFORCE Trial

AMBASSADOR

Testing the Addition of an Anti-cancer Drug, Pembrolizumab, to the Usual Intravesical Chemotherapy Treatment (Gemcitabine) for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer

Guiding Value of Urinary Tumor DNA Testing in Cystoscopy for High-Risk/Very High-Risk Non-Muscle-Invasive Bladder Cancer

Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer

ReplaceCysto

GAIN-BCG

In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial

Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG)

Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy in Muscle Invasive Bladder Cancer

Testing Anti-Cancer Drugs Erdafitinib With or Without Atezolizumab in Patients With Localized Bladder Cancer Not Able to Receive Cisplatin Chemotherapy, NERA Trial

MRI-guided Transurethral Urethral Ultrasound Ablation for the Treatment of Low to Intermediate Grade Prostate Cancer

Physicians' Perception About Patient Pain in Flexible Cystoscopy With Local Anesthesia

A Study Comparing a Disposable Flexible Cystoscope With Reusable Scopes in Adult Patients.

Phase 2 Durvalumab (Medi4736) for Bacillus Calmette-Guérin (BCG) Refactory Urothelial Carcinoma in Situ of the Bladder

Novel Urine-Based DNA Methylation Biomarkers for Urothelial Bladder Carcinoma Detection in Patients With Hematuria

The Efficacy of the Bladder EpiCheck for Detection of Recurrent Urothelial Cell Carcinoma

The Effect of Preemptive Analgesia On The Comfort Of Patient and Doctor, in Cystoscopy

Chemoradiation for Bladder Preservation After Complete Response to Neoadjuvant Chemotherapy

GEMCIRAV

Cystoscopy and Hexyl 5-Aminolevulinate in Detecting Carcinoma In Situ in Patients With Bladder Cancer